CDC’s Vital Signs Town Hall: The Public Health Response to CRE in Wisconsin

Safe Healthcare | Hosted by CDC’s Division of Healthcare Quality PromotionSafe Healthcare | Blogs | CDC

CDC’s Vital Signs Town Hall: The Public Health Response to CRE in Wisconsin

Today, on CDC's Safe Healthcare blog, Gwen Borlaug, MPH, CIC, Coordinator of the Healthcare-Associated Infections (HAI) Prevention Program in the Division of Public Health at the Wisconsin Department of Health Services, discusses the public health response to Carbapenem-resistant Enterobacteriaceae (CRE) in Wisconsin. The post is the third in a three-part series related to CDC’s August 2015 Vital Signs: Making Health Care Safer: Stop Spread of Antibiotic Resistance. 

Estimates in the Vital Signs report show that national infection control and antibiotic stewardship efforts led by federal agencies, health care facilities, and public health departments could prevent 619,000 antibiotic-resistant and C. difficile infections and save 37,000 lives over five years. While the coordinated approach this Vital Signs report describes is a forward-looking approach, some states are already implementing the response in a variety of different ways. This three-part blog series spotlights the current efforts in Tennessee, Illinois and Wisconsin.

Learn more and join the conversation at: http://blogs.cdc.gov/safehealthcare/?p=4590. Read about Tennessee’s geographic variation of CRE and implications for prevention and learn how Illinois has built a foundation for CRE control.

The Public Health Response to CRE in Wisconsin (Part 3 of a 3-part Series on the August 2015 Vital Signs: Making Health Care Safer: Stop Spread of Antibiotic Resistance)

The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria, Read More >

Posted on August 13, 2015 by DHQPLeave a comment

Categories Antibiotic use, Antimicrobial Resistance, Healthcare-associated infections

---

Building a Foundation for CRE Control in Illinois (Part 2 of a 3-part Series on the August 2015 Vital Signs: Making Health Care Safer: Stop Spread of Antibiotic Resistance)

The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria, Read More >

Posted on August 12, 2015 by CDC's Safe Healthcare BlogLeave a comment

Categories Antibiotic use, Antimicrobial Resistance, Healthcare-associated infections

---

Marked Geographic Variation of CRE in Tennessee and Implications for Prevention (Part 1 of a 3-part Series on the August 2015 Vital Signs: Making Health Care Safer: Stop Spread of Antibiotic Resistance)

The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria, Read More >

Posted on August 11, 2015 by CDC's Safe Healthcare BlogLeave a comment

Categories Antibiotic use, Antimicrobial Resistance, Clostridium difficile, Healthcare-associated infections

---

CDC Modeling Shows Safe Health Care Means Coordination

CDC’s Dr. Scott Fridkin Senior Advisor for Antibiotic Resistance in Health care Today CDC released its latest Vital Signs report, which includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. The report includes recommendations that would impact how health care Read More >

Posted on August 4, 2015 by CDC's Safe Healthcare BlogLeave a comment

Categories Antibiotic use, Antimicrobial Resistance, Clostridium difficile, Healthcare-associated infections

---

Consumer Reports looks at how well hospitals prevent common infections

A new analysis finds big differences in hospital performance against C. diff and MRSA infections. Guest Author: Teresa Carr Senior Editor, Best Buy Drugs Consumer Reports An estimated one in 25 patients develops at least one infection while in the hospital, according to the Centers for Disease Control and Prevention (CDC). But that number is Read More >

Posted on July 29, 2015 by DHQPLeave a comment

Categories HAI Guidelines, Healthcare-associated infections, Infection Control, Injection Safety, Long Term Care (LTC)